171 related articles for article (PubMed ID: 369991)
1. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
2. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
3. Nephropathy in the Wiskott-Aldrich syndrome.
Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
[TBL] [Abstract][Full Text] [Related]
4. Restoration of cell-mediated immune responses with transfer factor.
Kirkpatrick CH
Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
[TBL] [Abstract][Full Text] [Related]
5. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
[TBL] [Abstract][Full Text] [Related]
6. Transfer factor therapy: evidence for nonspecificity.
Ballow M; Dupont B; Hansen JA; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
[TBL] [Abstract][Full Text] [Related]
7. Transfer factor therapy in immunodeficiency.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
[No Abstract] [Full Text] [Related]
8. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
[TBL] [Abstract][Full Text] [Related]
9. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
[No Abstract] [Full Text] [Related]
10. Cellular immunity in acne vulgaris during transfer factor treatment.
Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of the transfer factor].
Mutz I; Humphrey GB
Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
[No Abstract] [Full Text] [Related]
12. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
Guss RB; McCulley JP
Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
[TBL] [Abstract][Full Text] [Related]
13. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
Mobacken H; Hanson LA; Lindholm L; Ljunggren C
Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
[TBL] [Abstract][Full Text] [Related]
14. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.
Kesarwala HH; Prasad RV; Szep R; Oldman E; Lane S; Papageorgiou PS
Clin Exp Immunol; 1979 Jun; 36(3):465-72. PubMed ID: 487648
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
Altman LC; Snyderman R; Blaese RM
J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
[TBL] [Abstract][Full Text] [Related]
16. Transfer factor therapy in mycosis fungoides: a double-blind study.
Thestrup-Pedersen K; Grunnet E; Zachariae H
Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
[No Abstract] [Full Text] [Related]
18. Randomized trial of transfer factor treatment of human warts.
Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of immunologic deficiency conditions by means of transfer factor].
Kobielowa Z
Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
[No Abstract] [Full Text] [Related]
20. Transfer factor II: results of therapy.
Spitler LE; Levin AS; Fudenberg HH
Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
